Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov;100(11):4082-91.
doi: 10.1210/jc.2015-2712. Epub 2015 Sep 17.

Phenotypic Characterization of Insulin-Resistant and Insulin-Sensitive Obesity

D L Chen  1 , C Liess  1 , A Poljak  1 , A Xu  1 , J Zhang  1 , C Thoma  1 , M Trenell  1 , B Milner  1 , A B Jenkins  1 , D J Chisholm  1 , D Samocha-Bonet  1 , J R Greenfield  1
Affiliations

Phenotypic Characterization of Insulin-Resistant and Insulin-Sensitive Obesity

D L Chen et al. J Clin Endocrinol Metab. 2015 Nov.

Erratum in

  • Corrections.
    [No authors listed] [No authors listed] J Clin Endocrinol Metab. 2016 Feb;101(2):757. doi: 10.1210/jc.2015-4260. Epub 2016 Jan 18. J Clin Endocrinol Metab. 2016. PMID: 26780570 No abstract available.
  • Corrections.
    [No authors listed] [No authors listed] J Clin Endocrinol Metab. 2016 Feb;101(2):757. doi: 10.1210/jc.2016-1108. Epub 2016 Jan 18. J Clin Endocrinol Metab. 2016. PMID: 26780571 No abstract available.

Abstract

Context: Whereas insulin resistance and obesity coexist, some obese individuals remain insulin sensitive.

Objective: We examined phenotypic and metabolic factors associated with insulin sensitivity in both muscle and liver in obese individuals.

Design and participants: Sixty-four nondiabetic obese adults (29 males) underwent hyperinsulinemic (15 and 80 mU/m(2) · min)-euglycemic clamps with deuterated glucose. Top tertile subjects for glucose infusion rate during the high-dose insulin clamp were assigned Musclesen and those in the lower two tertiles were assigned Muscleres. Secondarily, top tertile subjects for endogenous glucose production suppression during the low-dose insulin clamp were deemed Liversen and the remainder Liverres.

Main outcomes measures: Clinical and laboratory parameters and visceral, subcutaneous, liver, and pancreatic fat were compared.

Results: Musclesen and Muscleres had similar body mass index and total fat (P > .16), but Musclesen had lower glycated hemoglobin (P < .001) and systolic (P = .01) and diastolic (P = .03) blood pressure (BP). Despite similar sc fat (P = 1), Musclesen had lower visceral (P < .001) and liver (P < .001) fat. Liversen had lower visceral (P < .01) and liver (P < .01) fat and C-reactive protein (P = .02) than Liverres. When subjects were grouped by both glucose infusion rate during the high-dose insulin clamp and endogenous glucose production suppression, insulin sensitivity at either muscle or liver conferred apparent protection from the adverse metabolic features that characterized subjects insulin resistant at both sites. High-density lipoprotein-cholesterol, 1-hour glucose, systolic BP, and triglycerides explained 54% of the variance in muscle insulin sensitivity.

Conclusions: Obese subjects who were insulin sensitive at muscle and/or liver exhibited favorable metabolic features, including lower BP, liver and visceral adiposity. This study identifies factors associated with, and possibly contributing to, insulin sensitivity in obesity.

PubMed Disclaimer

Publication types

MeSH terms